CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials The Year in Cardiovascular Medicine 2020: Coronary Intervention Coronary Angiography after Cardiac Arrest without ST-Segment Elevation Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC’s Interventional Council and SCAI The year in cardiovascular medicine 2020: interventional cardiology Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study Safety and feasibility of robotic percutaneous coronary intervention: PRECISE (Percutaneous Robotically-Enhanced Coronary Intervention) Study

Recommandation StatementDecember 10, 2018 [Epub ahead]

JOURNAL:Arterioscler Thromb Vasc Biol. Article Link

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

CB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. Keywords: statin; ASCVD; risk; side effects; benefits

FULL TEXT PDF